SIC 3841 – Surgical and Medical Instruments and Apparatus
Valuation | |
---|---|
Market Cap ($M) | 67,554.01 |
Enterprise Value ($M) | 82,484.01 |
Book Value ($M) | 25,332.00 |
Book Value / Share | 87.68 |
Price / Book | 2.67 |
NCAV ($M) | -18,786.00 |
NCAV / Share | -65.03 |
Price / NCAV | -3.60 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.05 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.64 |
Current Ratio | 1.08 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8,156.00 |
Assets | 52,274.00 |
Liabilities | 26,942.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 19,372.00 |
Operating Income | 2,766.00 |
Net Income | 1,484.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 2,989.00 |
Cash from Investing | -716.00 |
Cash from Financing | -1,956.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Price T Rowe Associates Inc /md/ | 3.60 | 0.00 | |
13G/A | Vanguard Group Inc | 9.02 | 2.76 | |
13G/A | BlackRock Inc. | 7.90 | -4.23 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
179,761 | 723,399 | 24.85 | |
91,184 | 608,355 | 14.99 | |
133,132 | 607,733 | 21.91 | |
97,585 | 768,416 | 12.70 | |
(click for more detail) |
Financial data and stock pages provided by
Fintel.io